SCHEMBL7532099

SCHEMBL7532099

CC(SCC1CCN(C)CC1)C(C(=O)NO)N(C)S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
HTR2A P28223 6/20 0.44
HTR2C P28335 4/20 0.44
MMP1 P03956 7/20 0.42
MMP13 P45452 7/20 0.42
MMP9 P14780 7/20 0.42
ADAM17 P78536 4/20 0.42
MMP2 P08253 5/20 0.41
MMP8 P22894 4/20 0.41
MMP3 P08254 2/20 0.41
MMP14 P50281 1/20 0.41
MMP16 P51512 1/20 0.41
DUT P33316 1/20 0.39
ABCB11 O95342 1/20 0.38
CYP1A2 P05177 1/20 0.38
ADRB2 P07550 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7532093 1.00 L3MBTL1 (0.46) L3MBTL1APOBEC3AAPOBEC3GHTR2AHTR2C
SCHEMBL7541547 0.92 MMP9 (0.45) L3MBTL1HTR2AHTR2CMMP1MMP13
SCHEMBL7541543 0.92 MMP9 (0.45) L3MBTL1HTR2AHTR2CMMP1MMP13
SCHEMBL7535907 0.80 MMP9 (0.48) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL7535900 0.80 MMP9 (0.48) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL7531012 0.79 ADAMTS7 (0.51) L3MBTL1APOBEC3AAPOBEC3GHTR2AHTR2C
SCHEMBL7531009 0.79 ADAMTS7 (0.51) L3MBTL1APOBEC3AAPOBEC3GHTR2AHTR2C
SCHEMBL7532945 0.77 MMP9 (0.44) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL7532942 0.77 MMP9 (0.44) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL7537818 0.77 MMP9 (0.62) MMP1MMP13MMP9ADAM17MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US claimed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO claimed
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US disclosed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO disclosed